Metformin and Blood glucose decreased - a phase IV clinical study of FDA data

Summary:

Blood glucose decreased is found among people who take Metformin, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Metformin and have Blood glucose decreased. It is created by eHealthMe based on reports of 395,495 people who have side effects when taking Metformin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jun, 10, 2023

395,495 people reported to have side effects when taking Metformin.
Among them, 6,962 people (1.76%) have Blood glucose decreased.

What is Metformin?

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 406,290 Metformin users for its effectiveness, alternative drugs and more.

What is Blood glucose decreased?

Blood glucose decreased is found to be associated with 2,070 drugs and 1,322 conditions by eHealthMe.

Number of Metformin and Blood glucose decreased reports submitted per year:

Could Metformin cause Blood glucose decreased?

* Approximation only. Some reports may have incomplete information.

Do you take Metformin and have Blood glucose decreased?

Check whether Blood glucose decreased is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

T.Audi Yanto, I.Huang, F.Nathania Kosasih, NP Hardjo Lugito, "Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?", Case Reports in Endocrinology, 2018 Jan .
Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .

Related studies

How severe was Blood glucose decreased and when was it recovered:

Blood glucose decreased in Metformin

Expand to all the drugs that have ingredients of metformin hydrochloride:

Blood glucose decreased and drugs with ingredients of metformin hydrochloride (6,063 reports)

Alternative drugs to, pros and cons of Metformin:

Metformin (406,290 reports)

Common Metformin side effects:

Diarrhea: 25,489 reports
Fatigue (feeling of tiredness): 22,049 reports
Drug ineffective: 20,041 reports
Nausea and vomiting: 17,857 reports
Weight decreased: 17,682 reports
Breathing difficulty: 16,617 reports
Dizziness: 16,228 reports

Browse all side effects of Metformin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Blood glucose decreased treatments and more:

Blood glucose decreased (49,758 reports)

COVID vaccines that are related to Blood glucose decreased:

Common drugs associated with Blood glucose decreased:

All the drugs that are associated with Blood glucose decreased:

Blood glucose decreased (2,070 drugs)

Common conditions associated with Blood glucose decreased:

Type 2 diabetes: 12,907 reports
Diabetes: 6,513 reports
Type 1 diabetes: 3,050 reports

All the conditions that are associated with Blood glucose decreased:

Blood glucose decreased (1,322 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride (the active ingredients of Metformin) and Metformin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.